quinacrine has been researched along with Graft vs Host Disease in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeKlerk, JN | 1 |
| Murphy, GP | 1 |
| Van Zyl, JJ | 1 |
| Van Zyl, JA | 1 |
| Weber, HW | 1 |
| Brede, HD | 1 |
| Scott, WW | 1 |
1 other study available for quinacrine and Graft vs Host Disease
| Article | Year |
|---|---|
New methods of treatment for renal allotransplants using the baboon as a primate experimental model.
Topics: Animals; Antibodies; Azathioprine; Cyclophosphamide; Female; Globulins; Graft vs Host Disease; Haplo | 1969 |